Abstract
COVID-19 caused by the novel SARS Coronavirus-2 (SARS-CoV-2) is causing
serious blockades in the global public health sphere. In the absence of
specific antiviral treatment, exploration of plant-based products with
antiviral potential has gained attention. We present the research
prospects of utilizing coconut oil directly or its derivatives such as
monolaurin in treating COVID-19 with a special emphasis on the
biochemical characteristics features. The potential pitfalls therein and
way forward are also highlighted. Possibility of developing a medium
chain fatty acid-based nasal spray as a prophylactic or therapeutic is
also discussed. Nevertheless, the potential impediments in devising
suitable therapeutic models are also presented.